20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Depression is the leading cause of disability worldwide. Recent observations have revealed an association between mood disorders and alterations of the intestinal microbiota. Here, using unpredictable chronic mild stress (UCMS) as a mouse model of depression, we show that UCMS mice display phenotypic alterations, which could be transferred from UCMS donors to naïve recipient mice by fecal microbiota transplantation. The cellular and behavioral alterations observed in recipient mice were accompanied by a decrease in the endocannabinoid (eCB) signaling due to lower peripheral levels of fatty acid precursors of eCB ligands. The adverse effects of UCMS-transferred microbiota were alleviated by selectively enhancing the central eCB or by complementation with a strain of the Lactobacilli genus. Our findings provide a mechanistic scenario for how chronic stress, diet and gut microbiota generate a pathological feed-forward loop that contributes to despair behavior via the central eCB system.

          Abstract

          The gut microbiota may contribute to depression, but the underlying mechanism is not well understood. Here the authors use a mouse model of stress induced depression to demonstrate that behavioural changes conferred by fecal transplant from stressed to naïve mice require the endocannabinoid system.

          Related collections

          Most cited references79

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Role of the microbiota in immunity and inflammation.

            The microbiota plays a fundamental role on the induction, training, and function of the host immune system. In return, the immune system has largely evolved as a means to maintain the symbiotic relationship of the host with these highly diverse and evolving microbes. When operating optimally, this immune system-microbiota alliance allows the induction of protective responses to pathogens and the maintenance of regulatory pathways involved in the maintenance of tolerance to innocuous antigens. However, in high-income countries, overuse of antibiotics, changes in diet, and elimination of constitutive partners, such as nematodes, may have selected for a microbiota that lack the resilience and diversity required to establish balanced immune responses. This phenomenon is proposed to account for some of the dramatic rise in autoimmune and inflammatory disorders in parts of the world where our symbiotic relationship with the microbiota has been the most affected. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

              The intestinal microbiota influence neurodevelopment, modulate behavior, and contribute to neurological disorders. However, a functional link between gut bacteria and neurodegenerative diseases remains unexplored. Synucleinopathies are characterized by aggregation of the protein α-synuclein (αSyn), often resulting in motor dysfunction as exemplified by Parkinson's disease (PD). Using mice that overexpress αSyn, we report herein that gut microbiota are required for motor deficits, microglia activation, and αSyn pathology. Antibiotic treatment ameliorates, while microbial re-colonization promotes, pathophysiology in adult animals, suggesting that postnatal signaling between the gut and the brain modulates disease. Indeed, oral administration of specific microbial metabolites to germ-free mice promotes neuroinflammation and motor symptoms. Remarkably, colonization of αSyn-overexpressing mice with microbiota from PD-affected patients enhances physical impairments compared to microbiota transplants from healthy human donors. These findings reveal that gut bacteria regulate movement disorders in mice and suggest that alterations in the human microbiome represent a risk factor for PD.
                Bookmark

                Author and article information

                Contributors
                gerard.eberl@pasteur.fr
                pierre-marie.lledo@pasteur.fr
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                11 December 2020
                11 December 2020
                2020
                : 11
                : 6363
                Affiliations
                [1 ]GRID grid.428999.7, ISNI 0000 0001 2353 6535, Microenvironment and Immunity Unit, INSERM U1224, , Institut Pasteur, ; Paris, France
                [2 ]GRID grid.428999.7, ISNI 0000 0001 2353 6535, Perception and Memory Unit, CNRS UMR3571, , Institut Pasteur, ; Paris, France
                [3 ]GRID grid.428999.7, ISNI 0000 0001 2353 6535, Immunobiology of Infection Unit, INSERM U1221, , Institut Pasteur, ; Paris, France
                [4 ]GRID grid.428999.7, ISNI 0000 0001 2353 6535, Biology and Genetics of Bacterial Cell Wall Unit, CNRS UMR2001, INSERM, Equipe Avenir, , Institut Pasteur, ; Paris, France
                [5 ]GRID grid.457334.2, Université Paris Saclay, CEA, INRAE, Médicaments et Technologie pour la Santé (MTS), ; Gif-sur-Yvette, France
                [6 ]GRID grid.462143.6, ISNI 0000 0004 0382 6019, Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, Ecole Normale Supérieure de Lyon, CNRS UMR 5242, ; Lyon, France
                Author information
                http://orcid.org/0000-0003-4698-1206
                http://orcid.org/0000-0002-2731-8540
                http://orcid.org/0000-0001-8122-509X
                http://orcid.org/0000-0001-7848-586X
                http://orcid.org/0000-0002-8023-504X
                http://orcid.org/0000-0002-7781-7735
                http://orcid.org/0000-0002-4542-3053
                http://orcid.org/0000-0002-9390-7749
                http://orcid.org/0000-0002-1119-5638
                http://orcid.org/0000-0002-8156-7003
                Article
                19931
                10.1038/s41467-020-19931-2
                7732982
                33311466
                95973ff4-06d4-4485-8cd4-7e1708664063
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 28 May 2019
                : 6 November 2020
                Funding
                Funded by: Service de Pharmacologie et Immuno-Analyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay, MetaboHUB, F-91191, Gif-sur-Yvette, France
                Funded by: FundRef https://doi.org/10.13039/501100003762, Institut Pasteur;
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                microbiology,neural circuits,neurogenesis,stress and resilience
                Uncategorized
                microbiology, neural circuits, neurogenesis, stress and resilience

                Comments

                Comment on this article